{
  "patient_information": "Age: 25 years Sex: female Hiv status: positive Travel history: Zambia Symptoms onset: new-onset seizure Comorbidities: none reported Immunosuppression: advanced due to HIV infection Vaccination status: unknown Allergy info: unknown",
  "chief_complaint": "Symptoms: new-onset seizures Duration: recently diagnosed",
  "history_of_present_illness": "Timeline: recent onset of symptoms Key symptoms: seizures, altered mental status Pertinent negatives: no history of similar episodes Severity pattern: acute onset with rapid progression",
  "exposure_and_epidemiology": "Residence travel: Zambia Vectors animals: unknown Water food risks: unknown Contacts season outbreak: unknown Occupation: hospital cafeteria worker",
  "vitals": "Temperature: normal Blood pressure: normal Heart rate: normal Respiratory rate: normal Oxygen saturation: normal",
  "physical_exam": "General appearance: well-appearing Mental status: GCS 15/15 Neurological examination: unremarkable System reviews: no focal deficits, clear chest on auscultation",
  "labs_and_diagnostics": "Blood results: {\"wbc\": \"5.8 × 10^9/L (4–10)\", \"hemoglobin\": \"11.0 g/dL (12–14)\", \"platelets\": \"215 × 10^9/L (150–350)\", \"cd4_count\": \"153 cells/μL (500–1200)\", \"serum_sodium\": \"135 mmol/L (130–145)\", \"serum_glucose\": \"4.5 mmol/L (3.9–5.5)\"} Csf results: {\"leukocytes\": \"5 cells/μL (0–5)\", \"protein\": \"0.78 g/L (0.25–0.55)\", \"glucose\": \"2.9 mmol/L (2.25–2.97)\", \"cryptococcal_antigen\": \"negative\", \"india_ink_stain\": \"negative\", \"gram_stain\": \"negative\", \"ziehl_neelsen_stain\": \"negative\"} Additional tests: {\"malaria_rapid_test\": \"negative\", \"albuninuria\": \"normal\", \"cryptococcal_antigen\": \"negative\", \"india_ink_stain\": \"negative\", \"gram_stain\": \"negative\", \"ziehl_neelsen_stain\": \"negative\"}",
  "differential_diagnosis": "Considered conditions: [\"epilepsy\", \"tuberculosis meningitis\", \"cryptococcal meningitis\", \"progressive multifocal leukoencephalopathy (PML)\", \"cerebral toxoplasmosis\"] Evidence for: {\"epilepsy\": \"new-onset seizures, focal slowing on EEG\", \"tuberculosis meningitis\": \"normal CSF protein and glucose levels\", \"cryptococcal meningitis\": \"negative cryptococcal antigen test\", \"PML\": \"low CD4 count, normal CSF protein level\", \"cerebral toxoplasmosis\": \"no history of toxoplasmosis\"} Evidence against: {\"epilepsy\": \"normal CSF findings, no history of similar episodes\", \"tuberculosis meningitis\": \"negative India ink stain and gram stain\", \"cryptococcal meningitis\": \"negative cryptococcal antigen test\", \"PML\": \"no history of immunosuppression or exposure to Epstein-Barr virus\", \"cerebral toxoplasmosis\": \"normal CSF findings, no history of toxoplasmosis\"}",
  "management_and_clinical_course": "Initial treatment: phenobarbital for seizure control Antiretroviral therapy: started on ART Clinical improvement: seizure-free after 6 months Drug adjustments: carbamazepine added, phenobarbital stopped Outcome: remained seizure-free for 1 year",
  "final_diagnosis": "Diagnosis: progressive multifocal leukoencephalopathy (PML) Confirmation method: low CD4 count and normal CSF protein level Evidence for: {\"CD4_count\": \"low CD4 count\", \"CSF_protein_level\": \"normal CSF protein level\"} Evidence against: {\"epilepsy\": \"no history of similar episodes, normal CSF findings\", \"tuberculosis meningitis\": \"negative India ink stain and gram stain\", \"cryptococcal meningitis\": \"negative cryptococcal antigen test\", \"cerebral toxoplasmosis\": \"normal CSF findings\"}",
  "disease_name_short": "PML"
}